Clear Harbor Asset Management, LLC Leap Therapeutics, Inc. Transaction History

Clear Harbor Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 03, 2021	SELL	$1.35 - $4.01 $23,625 - $70,175	-17,500 Closed	0 $0
Q2 2021 Aug 06, 2021	SELL	$1.48 - $1.92 $21,460 - $27,840	-14,500 Reduced 45.31%	17,500 $29,000
Q1 2021 Apr 14, 2021	SELL	$1.82 - $3.01 $10,920 - $18,060	-6,000 Reduced 15.79%	32,000 $61,000
Q4 2020 Feb 04, 2021	BUY	$1.49 - $2.37 $56,620 - $90,060	38,000 New	38,000 $86,000

265K

Ticker LPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,021,400
Market Cap $275M
Description
Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate can...

Get notified when there are updates to the investment portfolio of Clear Harbor Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Clear Harbor Asset Management, LLC with notifications on news.